RxDoctor Payments Data

David Song

Plastic and Reconstructive Surgery · Washington, DCNPI 1043375884

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $964,448 of the $967,713 with a category attached, or 99.7%. Zimmer Biomet accounts for 99.8% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2019 at $544,791 and has fallen 99.9% since, to $474 in 2025.

$967,713in general payments, 2019–2025

Across 55 payments — averaging $17,595 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Zimmer Biomet$965K
  • Abbott$676
  • Surmodics, Inc.$558
  • Integra Lifesciences Corporation$520
  • Baxter Healthcare$144
  • Johnson & Johnson$139
  • plus $368 from 8 others

What the payments were for

  • Royalty or licence$964,448100%
  • Consulting fees$8600%
  • Travel & lodging$190%
  • Food & beverage$2,3860%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few plastic and reconstructive surgery providers in District of Columbiato place this figure against a meaningful peer group, so we don't.

Other plastic and reconstructive surgery in Washington

See the full list for District of Columbia

Where these figures come from

Is this you, or does something look wrong? →